Although ketorolac is one of the most potent anti-inflammatory and analgesic drugs, its use has been strongly limited owing to the high incidence of adverse effects reported, particularly in the gastrointestinal tract. Using the prodrug approach, which allows the reduction of toxicological features of the parent drug without altering its pharmacological properties, we synthesized an orally administrable prodrug of ketorolac by means of its reversible conjugation to D-galactose (ketogal). In a single dose study, its pharmacokinetic profile was compared with that of ketorolac. Moreover, we found that this prodrug was able to maintain the anti-inflammatory and the analgesic activity of the drug without giving rise to gastric ulcer formation. Thus, these results indicate that ketogal is a highly effective and valid therapeutic alternative to ketorolac itself.

Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations / A., Curcio; O., Sasso; Melisi, Daniela; M., Nieddu; LA RANA, Giovanna; Russo, Roberto; E., Gavini; G., Boatto; E., Abignente; Calignano, Antonio; Rimoli, MARIA GRAZIA. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 52:12(2009), pp. 3794-3800. [10.1021/jm900051r]

Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations

MELISI, DANIELA;LA RANA, GIOVANNA;RUSSO, ROBERTO;CALIGNANO, ANTONIO;RIMOLI, MARIA GRAZIA
2009

Abstract

Although ketorolac is one of the most potent anti-inflammatory and analgesic drugs, its use has been strongly limited owing to the high incidence of adverse effects reported, particularly in the gastrointestinal tract. Using the prodrug approach, which allows the reduction of toxicological features of the parent drug without altering its pharmacological properties, we synthesized an orally administrable prodrug of ketorolac by means of its reversible conjugation to D-galactose (ketogal). In a single dose study, its pharmacokinetic profile was compared with that of ketorolac. Moreover, we found that this prodrug was able to maintain the anti-inflammatory and the analgesic activity of the drug without giving rise to gastric ulcer formation. Thus, these results indicate that ketogal is a highly effective and valid therapeutic alternative to ketorolac itself.
2009
Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations / A., Curcio; O., Sasso; Melisi, Daniela; M., Nieddu; LA RANA, Giovanna; Russo, Roberto; E., Gavini; G., Boatto; E., Abignente; Calignano, Antonio; Rimoli, MARIA GRAZIA. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 52:12(2009), pp. 3794-3800. [10.1021/jm900051r]
File in questo prodotto:
File Dimensione Formato  
Curcio A JMC (2009).pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 258.2 kB
Formato Adobe PDF
258.2 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/352362
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 21
social impact